2
Clinical Trials associated with Autologous Rak Cells(Shanghai Pudong Hospital) / Unknown statusEarly Phase 1IIT Efficacy and Safety Evaluation of Percutaneous Ommaya Capsule Injection of Autologous Bi-dimensional Specific T Cells in the Treatment of Glioma and in Combination With Pemetrexed in the Treatment of Brain/Meningeal Metastases
Cerebral metastases are common intracranial tumor, its incidence increased year by year, in recent years, although the whole brain radiation therapy, surgical resection, stereotactic radiosurgery treatment, targeted drugs, and other comprehensive treatment in patients with symptoms of mitigation and the extension of survival has played a positive role, but due to individual differences, treatment in patients with poor compliance were a lot of factors, Further treatment of brain metastases after conventional treatment requires the assistance and cooperation of clinical multi-disciplines. To evaluate the efficacy and safety of percutaneous Ommaya capsule injection of autologous bi-dimensional specific T cells in the treatment of glioma and combined with pemetrexed in the treatment of brain/meningeal metastasis. Using translational research techniques and means, to find molecular indicators related to clinical prognosis and outcome, establish the clinical use standard of this holistic treatment technology, and popularize it in multi-centers.
/ Not yet recruitingPhase 2IIT Efficacy and safety of Thai recipes; Ha-rak, Juntaleela and Fatalaijone compare to Favipiravir in asymptomatic or mild COVID-19 patients
Start Date07 Oct 2021 |
Sponsor / Collaborator- |
100 Clinical Results associated with Autologous Rak Cells(Shanghai Pudong Hospital)
100 Translational Medicine associated with Autologous Rak Cells(Shanghai Pudong Hospital)
100 Patents (Medical) associated with Autologous Rak Cells(Shanghai Pudong Hospital)
100 Deals associated with Autologous Rak Cells(Shanghai Pudong Hospital)